Report Code : CVMI2603252601401 | Published Date : March 30, 2025
1 | Market Overview
The global carrier screening market is experiencing rapid growth due to increased demand for genetic testing, greater awareness of inherited disorders, and advances in next-generation sequencing (NGS) technologies. Carrier screening is conducted to identify if an individual carries a gene for specific genetic conditions that could be passed on to their children.
Growing focus on reproductive health, government support for genetic counseling, and a surge in IVF and preimplantation genetic diagnosis are driving increased demand. Advances in expanded carrier screening panels now enable simultaneous testing for hundreds of conditions, improving accessibility and accuracy.
2 | Market Size and Forecast
Year |
Market Value (USD Billion) |
Notes |
2019 |
1.32 |
Historical benchmark |
2024 |
2.15 |
Five-year CAGR 10.2% |
2031 |
4.87 |
Seven-year CAGR 12.1% |
The market is projected to more than double by 2031, driven by expanded reproductive genetics services and declining sequencing costs.
3 | Key Market Drivers
- Growing Awareness of Genetic Disorders: Higher demand for preconception and prenatal testing.
- Growth in IVF and Assisted Reproduction: Carrier screening is essential for fertility treatment.
- Advancements in NGS Technology: Faster, cheaper, and highly accurate testing.
- Government support for genetic health: Expanding newborn screening and genetic counseling programs.
4 | Market Challenges
- Ethical and psychological concerns: anxiety related to carrier status.
- Variable insurance coverage results in high costs in regions without universal healthcare.
- Regulatory Complexity: Varying standards for reporting variants of uncertain significance (VUS).
5 | Competitive Landscape
The market is moderately consolidated with key genomics and diagnostics companies leading globally, supported by laboratory service providers and health tech startups.
Market Share Estimates (2024):
Company |
Estimated Market Share |
Key Offerings |
Invitae Corporation |
22% |
Comprehensive carrier screening panels |
Natera Inc. |
18% |
Horizon™ Carrier Screening |
Myriad Genetics |
17% |
Foresight® Carrier Screen |
Fulgent Genetics |
11% |
Expanded panel testing |
Others (Quest, Labcorp, Sema4, GeneDx) |
32% |
Laboratory networks and regional providers |
6 | Market Segmentation
By Test Type:
- Targeted Carrier Screening
- Expanded Carrier Screening
By Technology:
- DNA Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Microarrays
By End User:
- Hospitals
- Clinical Laboratories
- IVF Centers
- Specialty Clinics
By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
7 | Strategic Outlook
Integration with digital health platforms, AI-driven variant interpretation, and consumer-centric genetic services will fuel future growth. Partnerships between labs, fertility clinics, and telehealth providers will accelerate access
Reasons To Buy

Scope

Key Players
- Natera
- Invitae
- Myriad Genetics
- LabCorp
- Quest Diagnostics
- Fulgent Genetics
- GeneDx
- BGI Genomics
- PerkinElmer
Carrier Screening Market Report
- 1. Carrier Screening Market Research Report
- 1.1 Study Objectives
- 1.2 Carrier Screening Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2. Carrier Screening Market Research Report - Preface
- 2.1 Carrier Screening Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Test Type:
- 2.1.2 By Technology:
- 2.1.3 By End User:
- 2.1.4 By Region
- 2.1 Carrier Screening Market Research Report – Detailed Scope and Definitions
- 3. Carrier Screening Market Dynamics
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Test Type:, By Technology:, By End User:, By Country
- 3.3. Opportunities – By Test Type:, By Technology:, By End User:, By Country
- 3.4. Trends – By Test Type:, By Technology:, By End User:, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Carrier Screening Market Research Report – DROTs Impact Analysis
-
- 4. Carrier Screening Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5. Carrier Screening Market, By Test Type:, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 5.1 Targeted Carrier Screening
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Expanded Carrier Screening
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 DNA Sequencing (NGS)
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Polymerase Chain Reaction (PCR)
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Microarrays
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Hospitals
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Clinical Laboratories
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 IVF Centers
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.4 Specialty Clinics
- 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8. Carrier Screening Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
- 8.1 North America
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 North America
- 9. North America Carrier Screening Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 9.1 By Test Type: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 9.1.1 Targeted Carrier Screening
- 9.1.2 Expanded Carrier Screening
- 9.2.1 DNA Sequencing (NGS)
- 9.2.2 Polymerase Chain Reaction (PCR)
- 9.2.3 Microarrays
- 9.3.1 Hospitals
- 9.3.2 Clinical Laboratories
- 9.3.3 IVF Centers
- 9.3.4 Specialty Clinics
- 9.4.1 United States
- 9.4.2 Canada
- 9.5 North America Carrier Screening Market – Opportunity Analysis Index, By Test Type:, By Technology:, By End User:, and Country, 2024 - 2031
- 9.6 Regional Trends Analysis
- 9.7 North America Carrier Screening Market Research Report - Company Profiles
- 9.7.1 Company 1 (United States)
- 9.7.2 Company 2 (Canada)
- 9.7.3 Company 3 (Canada)
- 10.1 By Test Type: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Targeted Carrier Screening
- 10.1.2 Expanded Carrier Screening
- 10.2.1 DNA Sequencing (NGS)
- 10.2.2 Polymerase Chain Reaction (PCR)
- 10.2.3 Microarrays
- 10.3.1 Hospitals
- 10.3.2 Clinical Laboratories
- 10.3.3 IVF Centers
- 10.3.4 Specialty Clinics
- 10.4.1 Germany
- 10.4.2 United Kingdom
- 10.4.3 France
- 10.4.4 Spain
- 10.4.5 Italy
- 10.4.6 Russia
- 10.5 Europe Carrier Screening Market – Opportunity Analysis Index, By Test Type:, By Technology:, By End User:, and Country, 2024 - 2031
- 10.6 Regional Trends Analysis
- 10.7 Europe Carrier Screening Market Research Report - Company Profiles
- 10.7.1 Company 1 (Germany)
- 10.7.2 Company 2 (United Kingdom)
- 10.7.3 Company 3 (United Kingdom)
- 11.1 By Test Type: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Targeted Carrier Screening
- 11.1.2 Expanded Carrier Screening
- 11.2.1 DNA Sequencing (NGS)
- 11.2.2 Polymerase Chain Reaction (PCR)
- 11.2.3 Microarrays
- 11.3.1 Hospitals
- 11.3.2 Clinical Laboratories
- 11.3.3 IVF Centers
- 11.3.4 Specialty Clinics
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 South Korea
- 11.4.5 Australia & New Zealand
- 11.4.6 ASEAN
- 11.5 Asia-Pacific Carrier Screening Market – Opportunity Analysis Index, By Test Type:, By Technology:, By End User:, and Country, 2024 - 2031
- 11.6 Regional Trends Analysis
- 11.7 Asia-Pacific Carrier Screening Market Research Report - Company Profiles
- 11.7.1 Company 1 (China)
- 11.7.2 Company 2 (Japan)
- 11.7.3 Company 3 (Japan)
- 12.1 By Test Type: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Targeted Carrier Screening
- 12.1.2 Expanded Carrier Screening
- 12.2.1 DNA Sequencing (NGS)
- 12.2.2 Polymerase Chain Reaction (PCR)
- 12.2.3 Microarrays
- 12.3.1 Hospitals
- 12.3.2 Clinical Laboratories
- 12.3.3 IVF Centers
- 12.3.4 Specialty Clinics
- 12.4.1 Brazil
- 12.4.2 Mexico
- 12.4.3 Argentina
- 12.4.4 Peru
- 12.4.5 Colombia
- 12.4.6 Rest of Latin America
- 12.5 Latin America Carrier Screening Market – Opportunity Analysis Index, By Test Type:, By Technology:, By End User:, and Country, 2024 - 2031
- 12.6 Regional Trends Analysis
- 12.7 Latin America Carrier Screening Market Research Report - Company Profiles
- 12.7.1 Company 1 (Brazil)
- 12.7.2 Company 2 (Mexico)
- 12.7.3 Company 3 (Mexico)
- 13.1 By Test Type: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Targeted Carrier Screening
- 13.1.2 Expanded Carrier Screening
- 13.2.1 DNA Sequencing (NGS)
- 13.2.2 Polymerase Chain Reaction (PCR)
- 13.2.3 Microarrays
- 13.3.1 Hospitals
- 13.3.2 Clinical Laboratories
- 13.3.3 IVF Centers
- 13.3.4 Specialty Clinics
- 13.4.1 Saudi Arabia
- 13.4.2 UAE
- 13.4.3 South Africa
- 13.4.4 Egypt
- 13.4.5 Israel
- 13.4.6 Rest of Middle East and Africa
- 13.5 Middle East and Africa Carrier Screening Market – Opportunity Analysis Index, By Test Type:, By Technology:, By End User:, and Country, 2024 - 2031
- 13.6 Regional Trends Analysis
- 13.7 Middle East and Africa Carrier Screening Market Research Report - Company Profiles
- 13.7.1 Company 1 (Saudi Arabia)
- 13.7.2 Company 2 (UAE)
- 13.7.3 Company 3 (UAE)
- 14.1 Strategic Dashboard of Top Market Players
- 14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
- 14.2.1 Thermo Fisher Scientific
- 14.2.2 Illumina
- 14.2.3 Fulgent Genetics
- 14.2.4 Myriad Genetics
- 14.2.5 Invitae Corporation
- 14.2.6 Natera Inc.
- 14.2.7 Eurofins Scientific
- 14.2.8 BGI Genomics
- 14.2.9 Centogene N.V.
- 14.2.10 Sema4
- 14.2.11 MedGenome
- 14.2.12 Gene by Gene
- 14.2.13 PerkinElmer Inc.
- 14.2.14 Quest Diagnostics
- 14.2.15 Roche Diagnostics
- 9.1 By Test Type: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 15. Data Collection Method and Research Approach
- 16. Principal Presumptions and Acronyms